Dr. Mitchell Receives Promotion to Research Scientist

FRI is pleased to announce that Dr. Mary Mitchell has been promoted from an Assistant Research Scientist to a Research Scientist, effective January, 2019. Dr. Mitchell joined FRI in September 2017. Since that time, she has contributed to a number of studies conducted at FRI while pursuing her own research. She will be serving as the Site Principal Investigator on the NIDA Clinical Trials Network Subthreshold Opioid Use Disorder Prevention (STOP) Trial. Dr. Mitchell is contributing to a variety of FRI projects including an Arnold Venture-funded evidence-based review of substance use disorder treatment. This review will be made available to US States to inform their use of the State Opioid Restitution Funding. Her recently published peer-reviewed articles have included a study examining longitudinal trends in blood alcohol content among patients treated for alcohol use disorder via a novel telemedicine intervention, and a study investigating HIV risk behaviors among pre-trial detainees in Baltimore, Maryland. Dr. Mitchell plans to continue applying advanced statistical techniques to study a variety of topics in substance use, especially longitudinal studies of cannabis use in pregnant and postpartum women and treatment outcomes for people with opioid use disorder. FRI would like to congratulate Dr. Mitchell on this notable achievement and wishes her a productive career with Friends.